No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Kezar Life Sciences Appoints New Principal Accounting Officer
Jefferies Maintains Kezar Life Sciences(KZR.US) With Buy Rating, Cuts Target Price to $18
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding AG (OtherRHHVF), Kezar Life Sciences (KZR) and Axsome Therapeutics (AXSM)
Kezar Life Sciences Reports Promising AIH Trial Results
Promising Clinical Trial Results and Safety Profile Justify Buy Rating for Kezar Life Sciences
Kezar Drops After Q4 Results and Mid-stage Data for Lead Asset